Effective Communication and Conflict Management

In this video, you will learn how to address conflicts in the healthcare environment by using effective communication techniques like emotional self-management, active listening, and speaking clearly.

Needs Statement

The Ethics, Professionalism, and Policy Program (EP3) is the ethics education curriculum created by the Center for Medical Ethics and Health Policy. The goal of the EP3 program is to educate the medical community about biomedical ethics. The EP3 topics are issues most medical providers encounter regularly but many feel unequipped to handle. The EP3 program’s goal is to provide easily digestible and actionable recommendations and resources about these complicated topics.

EDUCATIONAL METHODS

Lecture

EVALUATION

Evaluation by questionnaire will address program content, presentation, and possible bias.

Target Audience

This CME/CE activity is designed to meet the educational needs of physicians, residents, fellows, and community providers.

Learning Objectives

At the conclusion of this activity, the participant should be able to:

  • Recognize the importance of communication and conflict management among healthcare teams.

  • Describe skills that can be utilized to communicate more effectively and mitigate conflict.

  • List steps to improve skills necessary for effective communication and conflict management.

Course summary
Available credit: 
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 Ethics
  • 0.50 Participation
Course opens: 
12/01/2022
Course expires: 
12/31/2024
Rating: 
5

METHOD OF PARTICIPATION

In this video, you will learn how to address conflicts in the healthcare environment by using effective communication techniques like emotional self-management, active listening, and speaking clearly.

TO RECEIVE A CERTIFICATE YOU SHOULD:

  1. View the presentation in this enduring material.
  2. Complete and submit the evaluation form.
  3. The estimated time to complete this activity, including review of the materials, is 0.50 hour(s).

TERM OF APPROVAL

December 2022 through December 2024. Original release date: December 2022.

DISCLAIMER 

This activity is designed for use by healthcare professionals for educational purposes only. Information and opinion offered by the contributors represent their viewpoints. Conclusions drawn by the participant should be derived from careful consideration of all available scientific information. Prescription information and use of medical devices should be undertaken only after confirmation of information by consulting the FDA-approved uses and information.

Baylor College of Medicine makes every effort to have accurate information presented, no warranty, expressed or implied, is offered. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

Links are provided to other Internet sites solely for the convenience of users. Once you link to another site, you are subject to the site's terms and conditions of use including copyright and licensing restrictions.

DRUG/DEVICE STATUS DISCLOSURE

Some drugs/devices identified during this activity may have United States Food and Drug Administration (FDA) clearance for specific purposes only or for use in restricted research settings. The FDA has stated that it is the responsibility of the individual physician to determine the FDA status of each drug or device that he/she wishes to use in clinical practice and to use the products in compliance with applicable law.

Baylor College of Medicine requires that all faculty/presenters disclose an unlabeled use or investigational use of pharmaceutical and medical device products, and provide adequate scientific and clinical justification for such use.  Physicians are urged to fully review all the available data on products or procedures before using them to treat patients.

DISCLOSURE POLICY

Baylor College of Medicine (BCM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians.  BCM is committed to sponsoring CE activities that are scientifically based, accurate, current, and objectively presented.

In  accordance  with  the  ACCME  Standards for  Commercial Support, BCM has  implemented a mechanism requiring everyone in a position to control the content of an educational activity (i.e., directors, planning committee members, faculty) to disclose any relevant financial relationships with commercial interests (drug/device companies) and manage/resolve any conflicts of interest prior to the activity. Individuals must disclose to participants the existence or non-existence of financial relationships at the time of the activity or within 24 months prior.

In addition, BCM has requested activity faculty/presenters to disclose to participants any unlabeled use or investigational use of pharmaceutical/device products; to use scientific or generic names (not trade names) in referring to products; and, if necessary to use a trade name, to use the names of similar products or those within a class. Faculty/presenters have also been requested to adhere to the ACCME’s validation of clinical content statements.

BCM does not view the existence of financial relationships with commercial interests as implying bias or decreasing the value of a presentation. It is up to participants to determine whether the relationships influence the activity faculty with regard to exposition or conclusions.  If at any time during this activity you feel that there has been commercial/promotional bias, notify the Activity Director or Activity Coordinator. Please answer the questions about balance and objectivity in the activity evaluation candidly. 

All of the relevant financial relationships listed for these individuals have been mitigated.

Trevor Bibler, Ph.D., Lead Contributor
Assistant Professor
Center for Medical Ethics and Health Policy
Baylor College of Medicine
Houston, Texas
Disclosure: Nothing to disclose.

Jennifer Blumenthal-Barby, Ph.D., M.A., Planning Committee Member 
Cullen Associate Professor of Medical Ethics
Center for Medical Ethics and Health Policy
Baylor College of Medicine
Houston, Texas
Disclosure: Nothing to disclose.

Savitri Fedson, M.D., Planning Committee Member
Associate Professor
Center for Medical Ethics and Health Policy
Baylor College of Medicine
Houston, Texas
Disclosure: honorarium recipient: American Board of Internal Medicine.

Janet Malek, Ph.D., Planning Committee Member
Associate Professor
Center for Medical Ethics and Health Policy
Baylor College of Medicine
Houston, Texas
Disclosure: Nothing to disclose.

Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Baylor College of Medicine designates this enduring material activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.    

This activity has been designated by Baylor College of Medicine for 0.5 hours of education in medical ethics and/or professional responsibility.

Available Credit

  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 Ethics
  • 0.50 Participation
Please login or register to take this course.